Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Comparative Effects of Pharmacological Treatment on Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Zhang J, Wang Y, Li J, et al.
Drugs, 2026
Skeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review
Lai CH, Li YT, Wu TS, et al.
Archives of osteoporosis, 2026;21(1)
GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
Andronescu AC, Ciumărnean L, Orășan OH, et al.
International journal of molecular sciences, 2026;27(20)
Effects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review
Zheng YJ, Au HCT, Le GH, et al.
Acta neuropsychiatrica, 2026;38:e55
Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review
Gupta AK, Teasell EM, Magalhães RF, et al.
Medical sciences (Basel, Switzerland), 2026;14(6)
Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety
Poolton JT, Minett J, Kazmi A
Acta orthopaedica Belgica, 2026;92(3)
Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review
González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ, et al.
BMJ medicine, 2026;5(1):e002780
GLP-1-Based therapies for obesity-related heart failure with preserved ejection fraction: an umbrella review incorporating broader heart failure and cardiometabolic evidence
Li Q, Yang T, Jin G, et al.
Frontiers in cardiovascular medicine, 2026;13:1930278
Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients
Ali MF, Mohammed OF, Suhail A, et al.
Frontiers in cardiovascular medicine, 2026;13:1884895
GLP-1 Receptor Agonists in Heart Failure: A Systematic Review and Meta-analysis with Phenotype-Specific Effects and Dual Analytical Frameworks
Yuan Y, Chen C, Li X, et al.
Drugs, 2026
GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Beaudart C, Malréchauffé Y, van Heden S, et al.
Drugs, 2026
Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Zhong Y, Tan X, Zhang L, et al.
Frontiers in pharmacology, 2026;17:1916932
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis
Milluzzo A, Oteri V, Manuella L, et al.
International journal of obesity (2005), 2026
Body Composition and Lifestyle Interventions in Pharmacological Treatment of Acquired Hypothalamic Obesity: A Systematic Review of Randomized Controlled Trials
Yu H, Wang J, Yin M, et al.
Obesity (Silver Spring, Md.);34(9):1687-1698
Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes
Olubodun T, Osundina MA, Soyoye DO, et al.
PloS one, 2026;21(8):e0354497
Is There a Better Day of the Week to Administer Semaglutide or Tirzepatide? A Systematic Literature Review
La Vignera S, Condorelli RA
Medicina (Kaunas, Lithuania), 2026;62(8)
Peripheral nerve complications from medications utilised for weight loss: a systematic review
O'Gorman C, O'Gorman M, Warren N
Journal of neurology, 2026;273(8)
GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks
Roca Mora MM, Sanchez-Monge M, Balardini Ayoub D, et al.
Frontiers in psychiatry, 2026;17:1857078
Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists
Khatami S, Faghihi M, Tavakoli G, et al.
Cardiovascular toxicology, 2026;26(7)
Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis
Kishi T, Ikuta T, Sakuma K, et al.
Translational psychiatry, 2026